Multivirus-specific T cells (AlloVir product)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Multivirus-specific T cells (AlloVir product), covering 2021-07-19 to 2021-07-19. Get the full timeline:
Most recent: Clinical Trial Update: Multivirus-specific T Cells for the Treatment of Virus Infections After Stem Cell Transplant [NA]